QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Genworth Financial, Inc. (GNW)

Financial Services

No action
Fundamental
3
Sentiment
2
Technical
2

Do Nothing: qualitativeScore is 2 (below the required floor of 3) while fundamentalScore is 3 and price 8.67 is under the $25 ceiling; the strategy requires qualitativeScore ≥ 3 before any bullish entry and the shadow flag is false, so there is no paper carve-out. The chart independently offers no qualifying long either — price 8.67 is below SMA50 9.42 with MACD -0.17 (a countertrend pullback limit under the trend-alignment gate) and no momentum breakout exists below the settled 2026-11-05 high of 9.70.

Analysis as of 2026-11-11· more than 2 trading days ago

Company overview

Genworth Financial, Inc. provides mortgage and long-term care insurance products in the United States. It operates through the Enact and Closed Block segments, offering primary mortgage insurance and long-term care insurance. The company also offers life insurance and annuities, distributing products through sales representatives and digital marketing.

Fundamental

fair
Fundamental3
Mixed fundamentals

Strong balance sheet contrasts with deteriorating long-term care block, creating a mixed fundamental outlook.

Mixed. The balance sheet is genuinely strong - net cash, $1.48 billion of consolidated debt with no holding-company maturities until 2034, a 158% PMIERs ratio at Enact and roughly $443 million of trailing operating cash flow - and the shares change hands near 0.37x book with a 13.95% operating-cash-flow yield while the company retires about 7% of its shares a year. Against that, the long-term-care closed block is deteriorating quickly: the LTC adjusted operating loss widened to $261 million over nine months, actual-to-expected experience variances nearly doubled, statutory RBC at the legacy insurers fell from 300% to 274%, Q3 2026 produced a net loss, and management has pre-warned that the Q4 2026 reserve assumption review could be materially unfavorable. Trailing earnings are thin enough to put the P/E near 60, growth is negative across revenue, EPS and EBITDA, and a Principal Accounting Officer resignation plus a January 2027 CEO handover follow an FY2025 error correction. Deep value carrying a live reserve tail-risk - a mixed setup rather than a clean one.

Sentiment

weak
Sentiment2
Weak sentiment

Sentiment is weak with no immediate catalysts and unresolved uncertainties in long-term care reserves.

Dominant catalyst is the Q3 2026 print (announced, neutral reception): a $41M GAAP net loss with widening Closed Block and long-term-care losses, offset by a $500M buyback expansion and Enact-funded capital returns, leaving the two scored in-window items at roughly flat (-0.03). The sentiment delta is flat against a mildly positive baseline (+0.04 on 16 scored items), no forward-dated catalyst sits inside 30 trading days, Reddit was access-blocked so retail is unmeasurable, and the Red-Flag Screen is clean with neither a severe nor a moderate flag fired and no cap applied.

Technical

weak
Technical2
Bearish trend

Technical indicators suggest a bearish trend with no tradable bullish setup.

Bearish, bounce-only chart. Price 8.67 sits below the SMA20 (8.90), SMA50 (9.42), SMA200 (9.13), EMA9 (8.81) and EMA21 (8.95) after a lower-high sequence from the 2026-09-03 high of 10.69 into a fresh 8.615 low on 2026-11-11; MACD is flat at negative (-0.17 line / -0.17 signal / 0.00 histogram), RSI14 is 38.22 and ADX14 has faded to 23.35 from 34.69 on 2026-10-28. The only constructive reading is Williams %R at -94.93, which is oversold-bounce potential rather than a confirmed reversal. Liquidity and volatility are both tradeable (avgDollarVolume20 ~$32.0M, ATR14 3.00% of price), but the qualitative floor of 3 is not met (score 2), so no long is admitted regardless of the chart.

You’re looking at 2026-11-11 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.